Jeanne Marie Evans focuses her practice on mergers and acquisitions as well as regulatory, compliance and operational issues for healthcare companies. She works with a range of the firm’s healthcare clients, including hospitals and health systems, physician practice management companies, specialty pharmacies, health plan providers, and others.
Prior to joining Bass, Berry & Sims, Jeanne Marie was an associate at Kutak Rock LLP in Missouri where she provided regulatory guidance to healthcare clients. Jeanne Marie earned her law degree with a Certificate of Health Law from Saint Louis University School of Law and received a B.A. in history and communication studies from Loyola University of Chicago.
American Health Law Association (AHLA)
Representation of Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its sale of certain assets of Passport Health Plan, including Passport’s brand, operational and clinical infrastructure, and certain provider and vendor agreements, to Molina Healthcare, Inc.
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion
Representation of LucidHealth, a portfolio company of Excellere Partners, in its acquisition of Madison Radiologists
Representation of Clearway Pain Solutions, an interventional pain management medical practice that is backed by NexPhase, in its merger with KureSmart Pain Management
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Representation of Evolent Health Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, in its acquisition of the majority stake in Passport Health Plan for $70 million
Represented Consonance Capital Partners in the recapitalization of Orsini Pharmaceutical Services, LLC
Represented CHS in its sale of Gulf Oaks Behavioral Hospital
Saint Louis University Journal of Health Law and Policy — Lead Editor (2014-2015), Staff Editor (2013-2014)
Saint Louis University School of Law — Academic Excellence Award: Health Law; FDA Law and Policy; Fraud, Abuse and Healthcare; and Commercial Transactions